Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Elsevier
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===== Plan S open-access initiative ===== The [[Plan S]] open-access initiative, which began in Europe and has since spread to some US research funding agencies, would require researchers receiving some grants to publish in open-access journals by 2020.<ref name="US_funders">{{cite journal |last1=Noorden |first1=Richard Van |date=5 November 2018 |title=Wellcome and Gates join bold European open-access plan |url=https://www.nature.com/articles/d41586-018-07300-5 |url-status=live |journal=Nature |doi=10.1038/d41586-018-07300-5 |s2cid=239818967 |archive-url=https://web.archive.org/web/20201116071302/https://www.nature.com/articles/d41586-018-07300-5 |archive-date=16 November 2020 |access-date=16 January 2019|url-access=subscription }}</ref> A spokesman for Elsevier said "If you think that information should be free of charge, go to [[Wikipedia]]".<ref>{{cite news |last=Keulemans |first=Maarten |date=4 September 2018 |title=11 EU-landen besluiten: vanaf 2020 moet alle wetenschappelijke literatuur gratis beschikbaar zijn |url=https://www.volkskrant.nl/nieuws-achtergrond/11-eu-landen-besluiten-vanaf-2020-moet-alle-wetenschappelijke-literatuur-gratis-beschikbaar-zijn~be002c39/ |url-status=live |archive-url=https://web.archive.org/web/20180907221521/https://www.volkskrant.nl/nieuws-achtergrond/11-eu-landen-besluiten-vanaf-2020-moet-alle-wetenschappelijke-literatuur-gratis-beschikbaar-zijn~be002c39/ |archive-date=7 September 2018 |access-date=25 September 2018 |newspaper=De Volkskrant |language=nl |quote=Als je vindt dat informatie gratis moet zijn: ga naar Wikipedia.}}</ref> In September 2018, [[UBS]] advised to sell Elsevier (RELX) stocks, noting that Plan S could affect 5-10% of scientific funding and may force Elsevier to reduce pricing.<ref>{{cite news |last1=Elder |first1=Bryce |date=12 September 2018 |title=Stocks to watch: SSE, BAT, Galápagos, RELX, Telefónica, RBS |url=https://www.ft.com/content/2a2064e2-b669-11e8-bbc3-ccd7de085ffe |url-access=subscription |archive-url=https://ghostarchive.org/archive/20221210/https://www.ft.com/content/2a2064e2-b669-11e8-bbc3-ccd7de085ffe |archive-date=10 December 2022 |access-date=14 October 2018 |work=[[Financial Times]]}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)